Salestools LogoSalestools
Agenti IA Salestools
Soluzioni
Risorse
Azienda
Prezzi
Salestools Logo

Salestools

L'agente IA #1 per team di vendita e Go-to-Market. Vendi di più, più velocemente, con meno sforzo.

Prodotto

  • Agenti di vendita IA
  • Dati di intenzione
  • Dati Tecnologici
  • Tracciamento Visitatori
  • Co-Pilota
  • Vendita Sociale

Soluzioni

  • Servizio Clienti
  • E-commerce
  • SaaS
  • Impresa
  • Piccole Imprese

Risorse

  • Il rapporto
  • Documentazione
  • Riferimento API
  • Centro assistenza
  • Blog
  • Casi studio
  • Webinar

Azienda

  • Chi siamo
  • Carriere
  • Stampa
  • Contatto
  • Partner

Le nostre sedi

  • New York, HQ
  • Bucarest, Laboratorio di Ricerca IA
  • Zug, Svizzera

© 2025 Salestools. Tutti i diritti riservati.

Termini sui Dati e SicurezzaPolitica sulla privacyTermini di servizio
Tutti i sistemi operativi
Salestools LogoSalestools
Agenti IA Salestools
Soluzioni
Risorse
Azienda
Prezzi
Back to The Report
Fundraising

Inquis Medical

Inquis Medical Raises $40M in Series B

2018
Founded
70+
Employees
Menlo Park, CA
Updated November 9, 2024
2 min read

Quick Facts

Inquis Medical Raises $40M in Series B


Inquis Medical has successfully raised $40M in a Series B at a $200M valuation led by Marshall Wace, Cormorant Asset Management.


Company Overview


Inquis Medical is a HealthTech company headquartered in Menlo Park, CA, founded in 2018 with 70+ employees.


Medical technology company specializing in thrombectomy systems


Fundraising Details


  • Amount Raised: $40M
  • Round Type: Series B
  • Valuation: $200M
  • Date: 2024-11-09
  • Investors: Marshall Wace, Cormorant Asset Management

About Inquis Medical


Medical technology company specializing in thrombectomy systems The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Menlo Park, CA
  • Founded: 2018
  • Team Size: 70+
  • Industry: HealthTech

What This Means


This funding round demonstrates strong investor confidence in Inquis Medical's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Inquis Medical's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $200M valuation marks an important milestone for Inquis Medical, positioning the company among notable players in the HealthTech industry.


Looking Ahead


With this new capital, Inquis Medical is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-11-09. For more information about Inquis Medical, visit their headquarters at Menlo Park, CA.

Topics

Fundraising(2912)HealthTech(503)Series B(293)Inquis Medical

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million